Rectal cancer: When is the local recurrence risk low enough to refrain from the aim to prevent it?

Strahlentherapie und Onkologie

Volumn 189, Issue 2, 2013, Pages 105-110

  Sautter Bihl, M L ^a   Hohenberger, W ^b   Fietkau, R ^b   Rodel C ^c   Schmidberger, H ^d   Sauer, R ^b  

^a STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Neoadjuvant therapy; Radiation therapy; Radiochemotherapy; Surgery; Treatment outcome

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CHEMORADIOTHERAPY; CIRCUMFERENTIAL RESECTION MARGIN; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DIARRHEA; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LYMPH NODE; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PROCTITIS; RADIATION SICKNESS; RECTUM CANCER; RECTUM RESECTION; REVIEW; STOMATITIS;

EVIDENCE-BASED MEDICINE; GERMANY; HUMANS; NEOPLASM RECURRENCE, LOCAL; PREVALENCE; RECTAL NEOPLASMS; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 84874118778     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0299-5     Document Type: Review

References (47)

1. Al-Sukhni E, Milot L, Fruitman M et al (2012) Diagnostic accuray of MRI for assessment of T category, lymph node metastases, and circumferential re-section margin involvement in patients with rectal cancer: a systematic re-view and meta-analysis. Ann Surg Oncol 19:2212-2223
2. Bouchard P, Efron J (2010) Management of recurrent rectal cancer. Ann Surg Oncol 17:1343-1356
3. Bosset JF, Calais G, Mineur L et al (2005) Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results - EORTC 22921. J Clin Oncol 23:5620-5627
4. Bujko K, Nowacki MP, Nasierowska-Gunmejer A (2004) Sphincter preser-vation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72:15-24
5. Dent OF, Chapuis PH, Haboubi N, Bokey L (2011) Magnetic resonance imaging cannot predict histological tumour involvement of a circumferential surgical margin in rectal cancer. Colorectal Dis 13:974-981
6. Dewdney A, Cunningham D, Tabernero J et al (2012) Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperativ radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer. J Clin Oncol 30:1620-1627
7. Di Valentin, Alam Y, Ali-Alsharm A (2012) Eastern Canadian colorectal cancer consensus conference: application of new modalities of staging and treatment of gastrointestinal cancers. Curr Oncol 19:169-174
8. Fietkau R (2010) Rectal cancer: quo vadis, neoadjuvant and adjuvant (chemo) radiotherapy? Int J Colorectal Dis 25:285-287
9. Folkesson J, Birgisson H, Pahlman L et al (2005) Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survivial and local recurrence rate. J Clin Oncol 23:5644-5650
10. Gérard JP, Conroy T, Bonnetain F et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620-4625
11. Glimelius B (2012) Multidisciplinary treatment of patients with rectal cancer: development during the past decades and plans for the future. Ups J Med Sci 117:225-236
12. Glynne-Jones R, Mawdsley S, Pearce T, M. Buyse M (2006) Alternative clinical end points in rectal cancer - are we getting closer? Annals Oncol 17:1239-1248
13. Gwynne S, Webster R, Adams R et al (2012) Image-guided radiotherapy for rectal cancer: a systematic review. Clin Oncol (R Coll Radiol) 24:250-260
14. Gunderson LL, Sargent DJ, Tepper JE et al (2004) Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22:1785-1796
15. Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 28:1479-1482
16. Hellmann S (1997) Stopping metastases at their source. N Engl J Med 337:996-997
17. Hermanek P, Merkel S, Fietkau R et al (2010) Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TNM surgery. Implications for treatment decisions. Int J Colorectal Dis 25:359-368
18. Hermanek P, Hohenberger W, Fietkau R, Rödel C (2011) Individualized magnetic resonance imaging-based neoadjuvant chemoradiation for middle and lower rectal carinoma. Colorectal Dis 13:39-47
19. Hohenberger W, Merkel S, Hermanek P (2012) Volume and outcome in rectal cancer surgery: the importance of quality management. Int J Colorectal Dis. Nov 10 [Epub ahead of print]
20. Jabbour SK, Patel S, Hermann JM et al (2012) Intensity-modulated radia-tion therapy for rectal carcinoma can reduce breaks and emergency de-partment visits. Int J Surg Oncol 2012:891067 Epub 2012 Aug 13
21. Kosinski L, Habr-Gama A, Ludwig K et al (2012) Shifting concepts in rectal cancer management. CA Cancer J Clin 62:173-202
22. Maurer CA, Mattiello D, Duwe J et al (2012) Oncological short-term effects and adverse events of MRI-guided selective neoadjuvant radiochemother-apy for rectal cancer. Anticancer Res 32:1721-1728
23. MERCURY Study Group, Shihab OC, Taylor F (2011) Relevance of mag-netic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer. Br J Surg. 98:1798-1804
24. NCCN clinical practice guidelines in oncology. Rectal Cancer (2012) J National Comprehensive Cancer Network Version 3.2012
25. NICE clinical guideline 131 (2011) The diagnosis and management of colorectal cancer. Issued: November 2011 guidance.nice.org.uk/cg131. Accessed 12 December 2012
26. Nijkamp J, Kusters M, Beets-Tan RG et al (2011) Three-dimensional analy-sis of recurrence patterns in rectal cancer: the cranial border in hypofrac-tionated preoperative radiotherapy can be lowered. Int J Radiat Oncol Biol Phy 80:103-110
27. Ngan SY, Burmeister B, Fisher RJ et al (2012) Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04. J Clin Oncol 30:3827-33
28. Oberholzer K, Menig M, Kreft A et al (2012) Rectal cancer: mu-cinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation. Int J Radiat Oncol Biol Phys. 82:842-848
29. Patel UB, Taylor F, Blomqvist L et al (2011) Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol 29:3753-3760
30. Peeters KC, van de Velde CJ, Leer JW (2005) Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients - A Dutch Colorectal Cancer Group Study. J Clin Oncol 23:6199-6206
31. Quirke P, Steele R, Monson J et al (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG C016 ran-domised clinical trial. Lancet 373:821-828
32. Rödel C, Sauer R, Fietkau R (2009) Die Rolle der Magnetresonanztomo-graphie für die Indikationsstellung zur präoperativen Therapie beim Rektumkarzinom. Strahlenther Onkol 185:488-492
33. Rödel C, Arnold D, Becker H et al (2010) Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer: is it time for a randomized phase III trial? Strahlenther Onkol 186:658-664
34. Rödel C, Liersch T, Becker H et al (2012) Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouacil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AOI-04 randomised phase 3 trial. Lancet Oncol 13:679-687
35. Rosenberg J, Fischer A, Haglind E (2012) Current controversies in colorectal surgery: the way to resolve uncertainty and move forward. Colorectal Dis 14:266-269
36. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740
37. Sauer R, Liersch T, Merkel S et al (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the german CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30:1926-1933
38. Schmiegel W, Pox C, Reinacher-Schick A et al (2010) S3 guidelines for colorectal carcinoma: results of an evidence-based consensus conference on February 6/7, 2004 and June 8/9, 2007 (for the topics IV, VI and VII). Z Gastroenterol 48:65-136
39. Schmoll HJ, van Cutsem E, Stein A et al (2012) ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. An Oncol 23:2479-2516
40. Sebag-Montefiore D, Stephens RJ, Steele R et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373:811-820
41. Smith NJ, Barbachano Y, Norman AR et al (2008) Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 95:229-236
42. Strassburg J, Ruppert R, Ptok H et al (2011) MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study. Ann Surg Oncol 18:2790-2799
43. Taylor F, Quirke Ph, Heald RJ et al (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone. Ann Surg 253:711-719
44. Valentini V, van Stiphout RG, Lammering G et al (2011) Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials. J Clin Oncol 29:3163-3172
45. Van Gijn W, Marijnen AM, Nagtegaal ID et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal can-cer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575-582
46. Weiss C, Arnold D, Della K et al (2010) Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials. Int J Ra-diat Oncol Biol Phys 78:472-478
47. Wolff HA, Hennies S, Herrmann MK et al (2011) Comparison of the micronucleus and chromosome aberration techniques for the documentation of cytogenetic damage in radiochemotherapy-treated patients with rectal cancer. Strahlenther Onkol 187:52-58